Synlogic (SYBX) Revenue & Revenue Breakdown
Synlogic Revenue Highlights
Latest Revenue (Y)
$3.37M
Synlogic Revenue by Period
Synlogic Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.37M | 185.68% |
| 2022-12-31 | $1.18M | -32.73% |
| 2021-12-31 | $1.75M | 221.83% |
| 2020-12-31 | $545.00K | -75.49% |
| 2019-12-31 | $2.22M | -11.75% |
| 2018-12-31 | $2.52M | 3.11% |
| 2017-12-31 | $2.44M | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
Synlogic generated $3.37M in revenue during NA 2023, up 185.68% compared to the previous quarter, and up 133.77% compared to the same period a year ago.
Synlogic Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $8.00K | -99.71% |
| 2023-12-31 | $2.77M | 604.58% |
| 2023-09-30 | $393.00K | 1022.86% |
| 2023-06-30 | $35.00K | -79.89% |
| 2023-03-31 | $174.00K | 64.15% |
| 2022-12-31 | $106.00K | -84.37% |
| 2022-09-30 | $678.00K | 346.05% |
| 2022-06-30 | $152.00K | -37.70% |
| 2022-03-31 | $244.00K | -58.78% |
| 2021-12-31 | $592.00K | -35.37% |
| 2021-09-30 | $916.00K | 272.36% |
| 2021-06-30 | $246.00K | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2020-06-30 | $445.00K | 345.00% |
| 2020-03-31 | $100.00K | -91.87% |
| 2019-12-31 | $1.23M | 303.28% |
| 2019-09-30 | $305.00K | -12.86% |
| 2019-06-30 | $350.00K | 3.55% |
| 2019-03-31 | $338.00K | 204.50% |
| 2018-12-31 | $111.00K | -93.84% |
| 2018-09-30 | $1.80M | 609.06% |
| 2018-06-30 | $254.00K | -28.25% |
| 2018-03-31 | $354.00K | 218.92% |
| 2017-12-31 | $111.00K | - |
| 2017-09-30 | $111.00K | -94.74% |
| 2017-06-30 | $2.11M | 1801.80% |
| 2017-03-31 | $111.00K | - |
| 2016-12-31 | $111.00K | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | - |
Synlogic generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Synlogic Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ACIU | AC Immune SA | $14.80M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.89M |
| FRTX | Fresh Tracks Therapeutics | $8.01M | - |
| KRON | Kronos Bio | $6.29M | $2.37M |
| GBIO | Generation Bio | $5.90M | $4.09M |
| SYBX | Synlogic | $3.37M | - |
| SABS | SAB Biotherapeutics | $2.24M | $263.14K |
| VCNX | Vaccinex | $570.00K | $52.00K |
| CCCC | C4 Therapeutics | - | - |
| ANTX | AN2 Therapeutics | - | - |
| TARA | Protara Therapeutics | - | - |
| ERAS | Erasca | - | - |
| PCSA | Processa Pharmaceuticals | - | - |
| PASG | Passage Bio | - | - |
| MNPR | Monopar Therapeutics | - | - |
| THRD | Third Harmonic Bio | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| FDMT | 4D Molecular Therapeutics | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| SRZN | Surrozen | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |